Biologics for chronic rhinosinusitis with nasal polyps

Bachert C, et al.

J Allergy Clin Immunol · 2020

Grade Bnarrative review
DOI ↗

Key Findings

  • ●Comprehensive review of biologic mechanisms
  • ●Comparison of dupilumab, omalizumab, mepolizumab efficacy
  • ●Endotype-based treatment selection

Referenced in (1 disease)

Chronic Rhinosinusitis with Nasal Polyps
ID: doi-10-1016-j-jaci-2020-07-032DOI: 10.1016/j.jaci.2020.07.032